Literature DB >> 735882

Interaction by cholestyramine on the uptake of hydrocortisone in the gastrointestinal tract.

C Johansson, U Adamsson, U Stierner, T Lindsten.   

Abstract

An absolute reduction of the plasma cortisol levels and a delay of the peak concentrations were recorded in 10 healthy subjects, when a bile-sequestering anionic exchange resin, cholestyramine, was given prior to a single oral hydrocortisone dose, indicating that the resin interferes with the uptake of a neutral sterol in the human gastrointestinal tract. The possibility of a direct binding of drug to resin is supported by the affinity of hydrocortisone to cholestyramine in vitro, which was uninfluenced by the presence of sodium taurocholate. Cholestyramine significantly delayed the gastric emptying of a glucose solution, indicating that the resin not only decreases but also delays hydrocortisone absorption. Careful supervision is recommended when treatment with cholestyramine is given concomitant to neutral sterol drugs.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 735882     DOI: 10.1111/j.0954-6820.1978.tb08481.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  4 in total

Review 1.  A comparative review of the adverse effects of treatments for hyperlipidaemia.

Authors:  A Steiner; B Weisser; W Vetter
Journal:  Drug Saf       Date:  1991 Mar-Apr       Impact factor: 5.606

Review 2.  Adverse effects of hypolipidaemic drugs.

Authors:  L C Knodel; R L Talbert
Journal:  Med Toxicol       Date:  1987 Jan-Feb

Review 3.  Management of dyslipidemia in pediatric renal transplant recipients.

Authors:  Margret E Bock; Leslie Wall; Carly Dobrec; Mary Chandran; Jens Goebel
Journal:  Pediatr Nephrol       Date:  2020-01-02       Impact factor: 3.714

4.  Binding interactions with sevelamer and polystyrene sulfonate in vitro.

Authors:  Inge R F van Berlo-van de Laar; Ilona Prins-Can; Aliesa A de Lange; Katja Taxis; Frank G A Jansman
Journal:  Pharmacol Res Perspect       Date:  2021-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.